Tang Capital Management’s Calliditas Therapeutics CALT Stock Holding History
Bought
Maintained
Sold
Other funds holding CALT
CG
Tang Capital Management's CALT Position: Q1 2022 in Review
Tang Capital Management sold out of Calliditas Therapeutics (CALT) in Q1 2022, closing a stake of 100,000 shares — an estimated $2.48M sold.
Tang Capital Management first reported a position in CALT in Q4 2021 and held it in 1 quarter. The position peaked at $2.48M in Q4 2021. 17 funds tracked by Wall St. Rank hold CALT as of Q1 2022.
- Tang Capital Management reported no remaining Calliditas Therapeutics position as of Q1 2022 after selling out during the quarter.
- Tang Capital Management sold 100,000 Calliditas Therapeutics shares in Q1 2022, an estimated $2.48M.
- Tang Capital Management first reported a position in Calliditas Therapeutics in Q4 2021 and held it in 1 quarter.
- Tang Capital Management's Calliditas Therapeutics position peaked at $2.48M in Q4 2021.
- 17 funds tracked by Wall St. Rank held Calliditas Therapeutics as of Q1 2022.
Based on Tang Capital Management's 13F filing for Q1 2022, filed 16 May 2022.